RT Book, Section A1 Papadakis, Maxine A. A1 McPhee, Stephen J. A1 Rabow, Michael W. SR Print(0) ID 1175351101 T1 Mycotic Infections T2 Current Medical Diagnosis & Treatment 2021 YR 2021 FD 2021 PB McGraw-Hill Education PP New York, NY SN 9781260469868 LK accessmedicine.mhmedical.com/content.aspx?aid=1175351101 RD 2021/03/01 AB For Candida glabrata resistant to azoles and echinocandins, lipid formulation amphotericin B (3–5 mg/kg intravenously daily) may be used.